0 NYSE Companies - September 17, 2019Rafael Pharmaceuticals Announces Expansion into France of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®️ (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic CancerRead More
0 NYSE Companies - September 17, 2019Lift for the 22 and American Addiction Centers Host Suicide Awareness Event Focused on our Nation’s VeteransRead More
0 NYSE Companies - September 17, 2019Sonoco Alloyd Introduces Industry-Leading Five-Year Equipment WarrantyRead More
0 NYSE Companies - September 17, 2019News Reports about a Weakening Economy Impacting How Some Patients Seek Medical TreatmentRead More
0 NYSE Companies - September 17, 2019Meritage Homes announces continued strong order growth through August 2019Read More
0 NYSE Companies - September 17, 2019Philips launches NightBalance, increasing therapy options for positional obstructive sleep apnea patientsRead More
0 NYSE Companies - September 17, 2019Douglas Dynamics to Host Investor Event on October 4 at the NYSERead More
0 NYSE Companies - September 17, 2019Watsco Announces Advisory Board Appointments and Executive PromotionRead More
